IMARC Group, a leading market research company, has recently released a report titled “Dermatological Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the dermatological drugs market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the Dermatological Drugs Market?
The global dermatological drugs market size reached US$ 21.58 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.11 Billion by 2028, exhibiting a growth rate (CAGR) of 10.25% during 2023-2028.
What are Dermatological Drugs?
Dermatological drugs, or dermatology medications, are pharmaceutical substances specifically designed to diagnose, treat, and manage various skin conditions and disorders. The field of dermatology focuses on the study and treatment of skin, hair, and nail-related issues, making dermatological drugs essential for addressing numerous dermatological conditions. Some commonly known dermatological drug classes include corticosteroids, antifungals, antibiotics, antihistamines, retinoids, immunomodulators, and moisturizers. These drugs encompass various formulations, including topical creams, ointments, gels, lotions, and systemic medications in the form of tablets or injections. They target different aspects of skin health, such as inflammation, infection, cell proliferation, and immune responses. They manage conditions such as acne, eczema, psoriasis, fungal infections, dermatitis, rosacea, and vitiligo. Additionally, topical treatments are commonly prescribed for localized skin issues, while systemic medications are reserved for severe or widespread conditions. As a result, dermatological drugs are gaining immense traction across the globe.
Request for a sample copy of this report: https://www.imarcgroup.com/dermatological-drugs-market/requestsample
What are the growth prospects and trends in the dermatological drugs industry?
The dermatological drugs market is primarily driven by the prevalence of skin diseases, such as psoriasis, dermatitis, and allergies. In addition, the escalating demand for dermatological drugs, such as anti-aging creams, skin-lightening agents, and topical retinoids among consumers seeking solutions to address their specific skin concerns, is influencing the market growth. Moreover, the rising incidence of skin cancer and other serious dermatological conditions led to a growing demand for targeted therapies and specialized drugs, representing another major growth-inducing factor. Also, medical professionals and patients seek advanced treatment options to effectively combat these diseases while minimizing side effects. Consequently, pharmaceutical companies are developing personalized and precision-based dermatological drugs to cater to individual patient needs and offer enhanced therapeutic outcomes, which is augmenting the market growth. Besides this, the continuous advancement in biotechnology and pharmaceutical research resulted in the development of novel formulations and drug delivery systems that enhance the efficacy and convenience of dermatological treatments propelling market growth. For instance, the introduction of topical foams, gels, and patches is transforming the application of drugs, providing better absorption and patient compliance. Along with this, the growing environmental awareness, sustainability, and eco-consciousness are influencing the market landscape for environmentally friendly alternatives. As a result, the growing demand for dermatological drugs derived from natural ingredients with minimal environmental impact is providing a positive thrust to the market growth. Furthermore, pharmaceutical companies are investing in research and development (RD) to introduce innovative and effective treatment options, such as the development of eco-friendly dermatological drugs with reduced carbon footprints and lower volatile organic compound (VOC) emissions, creating a positive market outlook.
What is included in market segmentation?
The report has segmented the market into the following categories:
Dermatological Diseases Insights:
- Acne
- Dermatitis
- Psoriasis
- Skin Cancer
- Others
Route of Administration Insights:
- Oral
- Parenteral
- Topical
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Region:
- North America (United States, Canada)
- Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- AbbVie Inc.,
- Amgen Inc.,
- Bausch Health Companies Inc.,
- Bristol-Myers Squibb Company,
- Eli Lilly and Company,
- GSK plc,
- LEO Pharma A/S (LEO Holding A/S),
- Novartis AG,
- Pfizer Inc.,
- Sanofi S.A.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=reportid=7758flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
